8.2 ± 4.4, P < .0001) and more commonly male (62% vs 52%, P = .025). Compared to controls, more children with CRS were white (CRS 77% white; 10% black; 13% other vs control 47% white; 33% black; 20% other, P < .0001). Likewise, children with CRS were less commonly insured with Medical Assistance (CRS 14% vs control 43%, P < .0001).
Objective: The aim of study was to compare the postoperative complications associated with adenotonsillectomy with or without the application of FloSeal at the completion of the procedure in 2 similar groups.
Method: This retrospective study was performed at a tertiary care pediatric hospital between January 2007 and December 2008, for OSA and chronic tonsillitis in patients between 1 and 18 years old. Eight hundred patients underwent adenotonsillectomy in an identical manner, with half reciving FloSeal intraoperatively. Outcomes measured were: hemorrhage, return to OR, and dehydration.
Results: Age ranged from 1 to 18 years. Male gender was found to have a slight predominance without statistical significance (χ 2 = 0.01, P = .93). Preoperative diagnosis was more commonly OSA (79.9%) compared to chronic tonsillitis (20.1%). Primary bleed rate was found to occur in 2 subjects (0.3%); 1 FloSeal and 1 No FloSeal subject (χ 2 = 0.004, P = .95). Secondary bleeding was seen in 18 subjects (2.5%); 11 FloSeal and 7 No FloSeal (χ 2 = 1.32, P = .25). Dehydration was seen in 51 subjects (7.1%); 24 FloSeal and 27 No FloSeal (χ 2 = 0.01, P = .92). The need for return to OR was seen in 7 subjects (1%); 5 FloSeal and 2 No FloSeal (χ 2 = 1.59, P = .21).
Conclusion:
In our experience, the application of FloSeal hemostatic matrix after monopolar adenotonsillectomy demonstrates no additional reduction in postoerative complications encountered in the pediatric population.
Pediatric Otolaryngology Foreign Body as initial Symptom of Eosinophilic Esophagitis
Scott K. Hudson, MD (presenter); Chris Sampson; Harlan R. Muntz, MD; Fredrick Grimmer, MD; Albert H. Park, MD; W. Daniel Jackson; Marshall Smith, MD Objective: 1) Determine characteristics common in the presentation of esophageal foreign body that indicate presence of underlying esophageal pathology. 2) Provide clinical guidelines to consider esophageal mucosal biopsy during foreign body removal.
Method: Three hundred twelve cases of pediatric patients with an esophageal foreign body requiring esophagoscopy for removal were reviewed. Patients were excluded if a history of esophageal surgery or pathology was present. Factors common to those patients subsequently diagnosed with eosinophilic esophagitis (EE) were identified.
Results: Eligibility criteria were met in 271 cases. Of these, 27 underwent esophageal biopsy and 18 were diagnosed with EE. The following factors were compared between the EE population and the group as a whole: food impaction (89% of EE patients, 11% of non-EE patients), older age (average EE age 11.9, overall average age 4.5), atopic disease (61.1% of EE, 17.0% non-EE), abnormalities on esophagoscopy (94.4% of EE, 8.9% overall), and previous esophageal foreign body or frequent dysphagia (83.3% of EE, 5.9% non-EE). Eighteen percent of EE patients had 2 or more impactions requiring esophagoscopy prior to a biopsy being taken.
Conclusion:
Older age, food impaction, history of atopic disease or previous esophageal foreign body, and abnormalities on esophagoscopy are all associated with EE. Patients meeting these criteria should be strongly considered for mucosal biopsy during foreign body removal. Failure to do so may lead to repeated foreign body events.
Pediatric Otolaryngology
Genetic Assay for Newborn Auditory Screening Candice C. Colby, MD (presenter); N. Wendell Todd, MD, MPH; Xi Lin, PhD Objective: 1) Perform genetic screening on newborns that fail physiologic hearing screening and determine confirmed positives with hearing loss and false-positives. 2) Compare physiological screening results to genetic screening results and identify deafness genes. 3) Provide additional data to assist with the development and implementation of a universal protocol.
Method: Prospective, large-scale, multi-institution project examining genetic causes of hearing loss in newborn children at a tertiary-care academic center and private hospital that has the largest number of births in the country. The primary outcome measure is deafness genes. Data collection began January 2012 and is ongoing.
Results: Our hypothesis is that a majority of newborns confirmed to have hearing impairment based on physiological tests would have identifiable genetic mutations in the currently known 84 deafness genes. This genetic assay technology for identifying genetic abnormalities was tested in patients with known bilateral sensorineural hearing impairment and identified a genetic cause of hearing loss in 26 of 32 (81.3%) patients with usable specimens that were tested. The 2 most commonly identified
